VANTAGEMED CORP (VMDC) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 57 transactions totaling $2.4M, demonstrating a bearish sentiment with -$2.4M in net insider flow. The most recent transaction on Apr 20, 2007 involved a sale of 3,225,806 shares valued at $2.4M.
No significant insider buying has been recorded for VMDC in the recent period.
No significant insider selling has been recorded for VMDC in the recent period.
Based on recent SEC filings, insider sentiment for VMDC is bearish with an Insider Alignment Score of 1/100 and a net flow of -$2.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at VANTAGEMED CORP (VMDC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading VMDC stock, having executed 57 transactions in the past 90 days. The most active insider is Austin W. &. Greenhouse David M. Marxe (Executive), who has made 1 transactions totaling $2.4M.
Get notified when executives and directors at VMDC file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Apr 20, 2007 | W. &. Greenhouse David M. Marxe Austin | Executive | Sale | 3,225,806 | $0.75 | $2.4M | Large |
| Apr 18, 2007 | Altinger Richard | Executive | Disposition | 247,527 | $0.75 | $185.6K | |
| Apr 18, 2007 | Altinger Richard | Executive | Disposition | 110,000 | $0.75 | $82.5K | |
| Apr 18, 2007 | Cameron Mark | Executive | Option Exercise | 39,581 | $0.67 | $26.5K | |
| Apr 18, 2007 | Cameron Mark | Executive | Disposition | 77,583 | $0.75 | $58.2K | |
| Apr 18, 2007 | Loesch Liesel | Executive | Disposition | 30,000 | $0.75 | $22.5K | |
| Apr 18, 2007 | Loesch Liesel | Executive | Option Exercise | 30,000 | $0.20 | $6.0K | |
| Apr 18, 2007 | Philipp David | Executive | Option Exercise | 20,000 | $0.21 | $4.2K | |
| Apr 18, 2007 | Philipp David | Executive | Option Exercise | 20,000 | $0.55 | $11.0K | |
| Apr 18, 2007 | Philipp David | Executive | Option Exercise | 20,000 | $0.60 | $12.0K | |
| Apr 18, 2007 | Philipp David | Executive | Option Exercise | 30,000 | $0.45 | $13.5K | |
| Apr 18, 2007 | Philipp David | Executive | Disposition | 143,763 | $0.75 | $107.8K | |
| Apr 18, 2007 | Zabrowski David | Executive | Option Exercise | 20,000 | $0.45 | $9.0K | |
| Apr 18, 2007 | Zabrowski David | Executive | Option Exercise | 20,000 | $0.21 | $4.2K | |
| Apr 18, 2007 | Zabrowski David | Executive | Disposition | 80,000 | $0.75 | $60.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 1 | $2.4M | 50.7% |
Disposition(D) | 19 | $1.9M | 40.4% |
Exercise(M) | 35 | $407.2K | 8.5% |
Purchase(P) | 2 | $15.0K | 0.3% |
Insider selling pressure at VANTAGEMED CORP has increased, with 8 insiders executing 57 transactions across all time. Total sales of $2.4M significantly outpace purchases of $15.0K, resulting in a net outflow of $2.4M. This selling activity appears largely discretionary, which may warrant closer attention from investors.